A young woman dies in childbirth for lack of proper perinatal care. An elderly man can't afford meds to control his chronic conditions, so he rations them. A child is misdiagnosed in the emergency room. A patient waits months to see her doctor about a troublesome symptom.
Stories like these abound. They are shared by patients, parents, partners, good healthcare providers and others who've had enough of medical runarounds, cost issues, access problems, diagnostic and treatment errors, insufficient time with providers, and more, to contend with. Reports of major issues in healthcare by medical professionals as well as patients and politicians with a conscience are increasingly sounding alarms.
In a recent Instagram post, for example, Senator Tammy Baldwin (D-WI) was outraged to learn that drug companies charge as little as $7.00 for an inhaler outside the U.S. while here the price gouging rises to as much as $380 depending on what type of inhaler is needed. Senator Bernie Sanders (I-VT) is among several Democratic senators, and The Senate Health, Education, Labor and Pensions Committee, that have demanded information about asthma inhaler patents and prices from four major manufacturers accused of "manipulating the patent system."
One of the four companies was cited for charging $645 for an inhaler it sells in the UK for $49. Another company was called out for charging $286 on the U.S. market for an inhaler that costs $9.00 in Germany. According to another Instagram post in February, "Pharmaceutical giant Eli Lilly reported over two billion dollars in profit in the last three months of last year alone. This massive number comes from hiking prices of vital drugs for American seniors and other patients".
Dr. Ashish Jha, Dean of the School of Public Health at Brown University wrote in a Washington Post editorial in January expressing his concern that some doctors are selling their practices to private equity firms because running a medical practice has become a management nightmare. "The number of private equity firms in health care has exploded in recent years," Dr Jha lamented. "It's a trend that should have everyone's attention, from politicians to patients, because it can significantly increase costs, reduce access, and threaten patient safety."
In an article published in the New York Times in November last year, Dr. Amol Navathe, co-director of the Healthcare Transformation Institute at the University of Pennsylvania, worried that non-profit hospitals were focusing more on dollars than patients. He wrote that nonprofit hospitals are "hounding poor patients for money, cutting nursing staffing too aggressively, and giving preferential treatment to the rich." It's gotten so bad, he says, that nurses and other healthcare workers are resorting to strikes to improve workplace safety at several hospitals during an "acquisition spree" that is making healthcare less affordable.
Nursing homes and assisted living facilities are taking a hit too. According to the New York Times these profitable facilities charge $5,000 per month or more topped up by fees for such things as a blood pressure check, $50 for an injection (more for insulin), almost $100 a month for medication orders from external pharmacies, and over $300 a month for daily help with an overpriced inhaler. There can be extra charges for help in toileting, dining room fees, or a daily check in by staff.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
